Upstate NY Cancer Research & Education Foundation, Inc. - Interlakes Oncology/Hematology — Rochester, New York

Upstate NY Cancer Research & Education Foundation, Inc. - Interlakes Oncology/Hematology is a clinical research site located in Rochester, New York, United States 14623.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Upstate NY Cancer Research & Education Foundation, Inc. - Interlakes Oncology/Hematology has participated in 1 clinical trials.

Therapeutic areas: Non-Hodgkin's Lymphoma.

Sponsors: Cephalon.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Upstate NY Cancer Research & Education Foundation, Inc. - Interlakes Oncology/Hematology?

Upstate NY Cancer Research & Education Foundation, Inc. - Interlakes Oncology/Hematology has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Upstate NY Cancer Research & Education Foundation, Inc. - Interlakes Oncology/Hematology conducted?

Upstate NY Cancer Research & Education Foundation, Inc. - Interlakes Oncology/Hematology has 1 clinical trials on record. Their work covers Non-Hodgkin's Lymphoma.

Is Upstate NY Cancer Research & Education Foundation, Inc. - Interlakes Oncology/Hematology accredited by Crixeo Health?

Upstate NY Cancer Research & Education Foundation, Inc. - Interlakes Oncology/Hematology has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Upstate NY Cancer Research & Education Foundation, Inc. - Interlakes Oncology/Hematology?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.